MEDICAMEN BIOTECH
Back to Balance Sheet
|
MEDICAMEN BIOTECH Last 5 Year Total Liabilities History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Total Liabilities | ₹294 Cr | ₹292 Cr | ₹277 Cr | ₹225 Cr | ₹194 Cr |
What is the latest Total Liabilities ratio of MEDICAMEN BIOTECH ?
| Year | Total Liabilities |
|---|---|
| Mar2025 | ₹294 Cr |
| Mar2024 | ₹292 Cr |
| Mar2023 | ₹277 Cr |
| Mar2022 | ₹225 Cr |
| Mar2021 | ₹194 Cr |
How is Total Liabilities of MEDICAMEN BIOTECH Trending?
| Years | Total Liabilities | % Change | |
|---|---|---|---|
| Mar2025 | ₹294 Cr | 0.78 | |
| Mar2024 | ₹292 Cr | 5.57 | |
| Mar2023 | ₹277 Cr | 22.84 | |
| Mar2022 | ₹225 Cr | 16.08 | |
| Mar2021 | ₹194 Cr | - | |
Compare Total Liabilities of peers of MEDICAMEN BIOTECH
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| MEDICAMEN BIOTECH | ₹490.1 Cr | 1.2% | -7.7% | -26.1% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹409,698.0 Cr | 0.2% | -1.3% | -3.5% | Stock Analytics | |
| DIVIS LABORATORIES | ₹171,878.0 Cr | 1.9% | -6.7% | 0.4% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹138,062.0 Cr | 1.3% | 2.9% | 28.7% | Stock Analytics | |
| CIPLA | ₹109,030.0 Cr | 1.3% | -8.5% | -7.3% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹106,023.0 Cr | 1.3% | 3.8% | 4.5% | Stock Analytics | |
MEDICAMEN BIOTECH Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| MEDICAMEN BIOTECH | 1.2% |
-7.7% |
-26.1% |
| SENSEX | 0.6% |
0.1% |
9.2% |
You may also like the below Video Courses